ReviewJournal of audiology & otology2025
Practical Guidelines for Smartphone-Based Hearing Aid Application and Personal Sound Amplification Device Usage to Correct Hearing Loss in Korea Based on a Randomized Controlled Trial by the Patient-Centered Clinical Research Coordinating Center.
Review in Journal of audiology & otology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The prevalence of mild-to-moderate hearing loss is increasing due to noise exposure and an expanding elderly population. Despite the benefits of hearing aids, many individuals avoid them due to cost and incomplete awareness, opting instead for smartphone-based hearing aid applications (SHAAs) and personal sound amplification products (PSAPs). However, these devices are currently lacking official approval for medical use. The study results, together with roundtable discussions organized by the Patient-Centered Clinical Research Coordinating Center (PACEN) and recent research findings, were reviewed to develop clinical guidelines. The roundtable discussions involved seven otology experts and one lay representative and focused on defining PSAPs and establishing minimum requirements for their use by patients with hearing loss. Hearing aids were found to effectively address all types of hearing loss and improve speech recognition in noisy environments. In contrast, SHAA and PSAP are effective only under specific conditions: SHAA for mild loss and PSAP for mild-to-moderate loss. Both devices perform poorly in noisy settings and lack noise processing features. Hearing aids are recommended as the most effective and versatile option for auditory rehabilitation, whereas SHAA and PSAP should only be considered under defined conditions when hearing aids are impractical. Continued updates and cost-effectiveness evaluations will be required as technologies advance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.